The breakthrough approach addresses a long-standing problem in cancer therapy by delivering drugs precisely to treatment-resistant leukemia stem cells without affecting healthy cells, with patient trials planned next.
CWRU, MetroHealth develop targeted therapy for relapsed leukemia
Source: Cleveland
Read Full Story →
